Naturhouse Health, S.A. (BME:NTH)
Spain · Delayed Price · Currency is EUR 2.520
-0.030 (-1.18%)
Aug 7, 2026, 2:12 PM CET
Naturhouse Health Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 153 | 132 | 99 | 97 | 95 | 115 | |
Market Cap Growth | 37.84% | 32.93% | 2.16% | 2.53% | -17.92% | 24.19% |
Enterprise Value | 141.84 | 121.82 | 82.81 | 80.78 | 87.99 | 92.52 |
Last Close Price | 2.52 | 2.20 | 1.66 | 1.62 | 1.58 | 1.93 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.14 | 12.94 | 10.34 | 8.53 | 9.88 | 8.75 |
Forward PE | - | 13.75 | 9.74 | 11.37 | 7.68 | 8.46 |
PEG Ratio | - | 9.89 | 9.89 | 9.89 | 8.54 | 0.51 |
PS Ratio | 3.21 | 2.77 | 2.01 | 1.93 | 1.81 | 2.00 |
PB Ratio | 8.61 | 7.43 | 3.13 | 3.17 | 3.40 | 3.20 |
P/TBV Ratio | 8.69 | 7.59 | 3.17 | 3.22 | 4.07 | 3.53 |
P/FCF Ratio | 13.10 | 10.86 | 8.58 | 4.64 | 13.35 | 7.14 |
P/OCF Ratio | 12.59 | 10.86 | 8.58 | 4.64 | 13.35 | 7.14 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.98 | 2.56 | 1.68 | 1.60 | 1.68 | 1.61 |
EV/EBITDA Ratio | 9.94 | 8.54 | 5.48 | 4.36 | 5.81 | 4.67 |
EV/EBIT Ratio | 10.80 | 9.27 | 6.30 | 4.97 | 6.85 | 5.34 |
EV/FCF Ratio | 12.15 | 10.03 | 7.16 | 3.86 | 12.40 | 5.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.19 | 0.19 | 0.13 | 0.26 | 0.19 | 0.12 |
Debt / EBITDA Ratio | 0.24 | 0.24 | 0.28 | 0.44 | 0.36 | 0.22 |
Debt / FCF Ratio | 0.28 | 0.28 | 0.37 | 0.38 | 0.76 | 0.27 |
Net Debt / Equity Ratio | -0.57 | -0.57 | -0.52 | -0.53 | -0.24 | -0.63 |
Net Debt / EBITDA Ratio | -0.71 | -0.71 | -1.09 | -0.88 | -0.44 | -1.16 |
Net Debt / FCF Ratio | -0.83 | -0.83 | -1.42 | -0.78 | -0.95 | -1.41 |
Asset Turnover | 1.25 | 1.25 | 1.08 | 1.10 | 1.14 | 1.26 |
Inventory Turnover | 4.20 | 4.20 | 4.51 | 5.05 | 5.72 | 5.63 |
Quick Ratio | 1.29 | 1.29 | 3.61 | 2.23 | 2.53 | 4.21 |
Current Ratio | 1.65 | 1.65 | 4.36 | 2.69 | 3.23 | 4.62 |
Return on Equity (ROE) | 40.83% | 40.83% | 31.65% | 38.45% | 30.09% | 43.04% |
Return on Assets (ROA) | 25.47% | 25.47% | 20.95% | 25.89% | 20.55% | 27.74% |
Return on Invested Capital (ROIC) | 125.98% | 84.33% | 64.76% | 66.98% | 54.96% | 144.21% |
Return on Capital Employed (ROCE) | 45.55% | 45.55% | 36.42% | 46.13% | 34.11% | 48.03% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.60% | 7.73% | 9.67% | 11.73% | 10.13% | 11.43% |
FCF Yield | 7.64% | 9.21% | 11.65% | 21.57% | 7.49% | 14.01% |
Dividend Yield | 7.78% | 13.65% | 12.09% | 6.18% | 19.00% | 3.12% |
Payout Ratio | 178.32% | 178.32% | 121.67% | 53.13% | 186.97% | 26.94% |
Total Shareholder Return | 7.78% | 13.65% | 12.09% | 6.18% | 19.00% | 3.12% |